Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020 Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover...